Tempus AI, Inc. and Predicta Biosciences recently expanded the commercial rollout of their co-branded GenoPredicta™ whole-genome sequencing assay, which combines flow cytometry and ultra-sensitive ...
Dayhoff Health and AMD publish a joint white paper documenting up to 330× faster microbiome processing, 13–22× faster ...
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, and Predicta ...
Shares of Tempus AI rose after the medical technology company said it was expanding the commercial availability of whole-genome sequencing assay technology to detect and analyze cancer cells in ...
A federally funded study is coming to Minnesota to determine if whole genome sequencing at birth can reduce childhood ...
Whole genome sequencing offered to breast cancer patients is likely to identify unique genetic features that could either guide immediate treatment or help match patients to clinical trials for over ...
A whole-genome sequencing approach shows early promise over current commercial methods for identifying more patients likely to benefit from PARP inhibitor cancer treatments, according to a study led ...
Find the latest Whole Genome Sequencing news from WIRED. See related science and technology articles, photos, slideshows and ...
Holly has a degree in Medical Biochemistry from the University of Leicester. Her scientific interests include genomics, personalized medicine, and bioethics.View full profile Holly has a degree in ...
A study from Columbia University Mailman School of Public Health reports a major advance in understanding how interactions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results